Summary by Moomoo AI
Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the stock's performance.